Healthcare & Life Sciences
C10 Pharma
Norway
series-a
series-a
Stage
1
Investors
About
C10 Pharma is developing a new compound intended for the treatment of bacterial infections.
Explore C10 Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.